Octagon Capital Advisors LP Reports 10.1% Passive Stake in AN2 Therapeutics as of June 13 - SEC Filing
Octagon Capital Advisors LP報告於6月13日持有AN2 Therapeutics公司10.1%的被動股份 - 根據SEC文件
Octagon Capital Advisors LP Reports 10.1% Passive Stake in AN2 Therapeutics as of June 13 - SEC Filing
Octagon Capital Advisors LP報告於6月13日持有AN2 Therapeutics公司10.1%的被動股份 - 根據SEC文件
譯文內容由第三人軟體翻譯。